Dynasty Market Report — October 19, 2026
The Lede
Germie Bernard is the dynasty story of the week. His +46.07% surge to DME 1,598 in a single seven-day window is the kind of move that separates managers who were already holding from those who are about to dramatically overpay. The Pittsburgh offense has found its guy, and the market is just now catching up.
Who's Rising
Bernard's climb to DME 1,598 is the headliner, but Travis Hunter's +48.59% move to DME 1,156 deserves equal attention — Jacksonville appears to have committed to Hunter as a legitimate weekly starter, and at that DME he still carries credible upside if the role holds. Josh Jacobs at DME 2,013 (+27.41%) is the most straightforward story: four consecutive quality performances have reminded managers that elite RB production ages better than the market priced him six months ago, and Eli Raridon's breakout to DME 1,201 in New England suggests the rookie TE pipeline just delivered a real one. Buy Raridon now — that number moves again next week.
Who's Falling
Omarion Hampton's -13.4% drop to DME 3,528 is directly tied to the Harbaugh bye-week narrative — a 0-6 Chargers start is systemic dysfunction, not a running back problem, and Hampton's talent floor keeps this a hold rather than a sell. Marvin Harrison Jr. crashing to DME 2,312 (-19.55%) alongside a Cardinals offensive line that apparently needs a kicker to win games is more concerning; this is a buy-low window only if you believe in scheme correction, which right now is a significant ask. Bo Nix at DME 3,901 after a -14.97% slide is a nuanced sell in Superflex — that DME still feels inflated if Denver's infrastructure doesn't stabilize.
The Move
Sell Bo Nix (DME 3,901) into any remaining belief and flip the return directly into Eli Raridon (DME 1,201). Nix's window for recovery is narrow and crowded with competition above him; Raridon is a ascending rookie TE in a system that historically manufactures fantasy-relevant tight ends, and you're buying him before the second wave of price discovery hits.